EQS-Adhoc: MEDIQON Group AG: Capital Increase from Authorized Capital Resolved
|
EQS-Ad-hoc: MEDIQON Group AG / Key word(s): Corporate Action
MEDIQON Group AG: Capital Increase from Authorized Capital Resolved
12-Dec-2022 / 18:06 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Today, the Management Board (with the approval of the Supervisory Board) of MEDIQON Group AG (ISIN: DE0006618309) resolved a capital increase from authorized capital with the exclusion of subscription rights by issuing up to 10% of its registered share capital of EUR 14,999,333.00. The Company expects to raise EUR 10 to 20 million.
The new shares will be offered exclusively to professional investors in a private placement to be finalized Tuesday morning, Dec 13, 2022. The issue price is set at EUR 14.50 per new share.
The funds raised by the capital increase are supposed to further accelerate the Company's growth.
12-Dec-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
|
| Language: |
English |
| Company: |
MEDIQON Group AG |
|
Herzog-Adolph-Strasse 2 |
|
61462 Königstein im Taunus |
|
Germany |
| Phone: |
+49 (0) 6174-9687040 |
| Fax: |
+49 (0) 6174-9687043 |
| E-mail: |
[email protected] |
| Internet: |
www.mediqon-group.de |
| ISIN: |
DE0006618309, DE000A254TL0 |
| WKN: |
661830, A254TL |
| Listed: |
Regulated Unofficial Market in Berlin, Frankfurt (Basic Board), Stuttgart |
| EQS News ID: |
1511009 |
| |
| End of Announcement |
EQS News Service |
1511009 12-Dec-2022 CET/CEST
|
Die wichtigsten Finanzdaten auf einen Blick
|
| |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
| Umsatzerlöse1 |
3,21 |
2,64 |
0,10 |
1,08 |
28,66 |
42,07 |
70,77 |
| EBITDA1,2 |
0,72 |
8,99 |
-0,44 |
-0,61 |
6,21 |
10,50 |
10,80 |
| EBITDA-Marge3 |
22,43 |
340,53 |
-440,00 |
-56,48 |
21,67 |
24,96 |
|
| EBIT1,4 |
0,51 |
8,65 |
-5,51 |
-2,56 |
0,94 |
2,51 |
-1,68 |
| EBIT-Marge5 |
15,89 |
327,65 |
-5.510,00 |
-237,04 |
3,28 |
5,97 |
-2,37 |
| Jahresüberschuss1 |
0,54 |
7,51 |
-5,01 |
-2,27 |
-2,27 |
-6,60 |
-6,39 |
| Netto-Marge6 |
16,82 |
284,47 |
-5.010,00 |
-210,19 |
-7,92 |
-15,69 |
-9,03 |
| Cashflow1,7 |
0,75 |
7,85 |
-5,00 |
-1,13 |
2,87 |
5,69 |
7,37 |
| Ergebnis je Aktie8 |
0,24 |
3,04 |
-1,50 |
-0,18 |
0,38 |
0,05 |
-0,23 |
| Dividende8 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
0,00 |
Quelle: boersengefluester.de und Firmenangaben
Geschäftsbericht 2023 - Kostenfrei herunterladen. 
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de
Wirtschaftsprüfer: BDO
|
| INVESTOR-INFORMATIONEN |
| ©boersengefluester.de |
| Chapters Group |
| WKN |
Kurs in € |
Einschätzung |
Börsenwert in Mio. € |
| 661830 |
23,200 |
Kaufen |
533,28 |
| KGV 2025e |
KGV 10Y-Ø |
BGFL-Ratio |
Shiller-KGV |
| 44,62 |
17,40 |
2,63 |
92,80 |
| KBV |
KCV |
KUV |
EV/EBITDA |
| 2,67 |
72,40 |
7,54 |
49,73 |
| Dividende '22 in € |
Dividende '23 in € |
Div.-Rendite '23
in % |
Hauptversammlung |
| 0,00 |
0,00 |
0,00 |
09.07.2024 |
| Q1-Zahlen |
Q2-Zahlen |
Q3-Zahlen |
Bilanz-PK |
|
18.10.2024 |
|
27.05.2024 |
| Abstand 60Tage-Linie |
Abstand 200Tage-Linie |
Performance YtD |
Performance 52 Wochen |
| -2,68% |
-0,08% |
26,78% |
37,28% |
|
|
MEDIQON Group AG DE0006618309